Germany’s Landmark Compassionate Use Program for Psilocybin: A New Wave for Psychedelic Medicine in Europe August 6, 2025
Clinical Trial into Psilocybin Therapy for Psychological Distress in Palliative Care, PsyPal, Receives Medical Ethical Authorisation, with Conditions December 20, 2024
Harnessing Psychedelics for Neurofeedback: A New Frontier in Executive Function Improvement November 28, 2024
Psychedelics vs. Traditional Treatments —How Do They Stack Up for Mental Health Disorders? – Part 1 November 7, 2024
The FDA’s Decision on MDMA-Assisted Psychotherapy: A Call for Pragmatism and Scientific Rigor August 21, 2024
